Pharmatek Laboratories, Inc. has successfully met Drug Enforcement Agency (DEA) requirements for the development and manufacture of Schedule IV and V controlled substances. “Based on the needs of our clients, Pharmatek has put significant systems in place for the handling, inventory, development and manufacture of controlled substances,” said Kevin Rosenthal, director of manufacturing. “Being registered by the DEA validates our facility design, security systems, and procedures for manufacturi...